TCR2
TCR2 is a discovery stage pharmaceutical company focused on engineering T cells for cancer therapy. The company's vast expertise in T cell engagement and a deep understanding of T cell receptor biology enabled the creation of a novel first-in-class approach that is highly differentiated from CAR-T cells and from T cells engineered to express defined TCR alpha/beta chains. TCR2 was founded by Dr. Patrick Baeuerle and MPM Capital. It has scientific operations in Kendall Square, Cambridge, Massachusetts to leverage best-in-class technologies and nucleate top-tier academic laboratories around the world.
TCR2
Industry:
Biotechnology Health Care Life Science Medical Pharmaceutical Therapeutics
Founded:
2015-01-01
Address:
Cambridge, Massachusetts, United States
Country:
United States
Website Url:
http://www.tcr2.com
Total Employee:
101+
Status:
Active
Contact:
617.475.8469
Total Funding:
173.3 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Analytics LetsEncrypt WordPress Google Universal Analytics Wordpress Plugins Nginx
Similar Organizations
Aimmune Therapeutics
Aimmune Therapeutics is a clinical-stage biopharmaceutical company that improves the lives of people with food allergies.
Axcella
Axcella is a biotechnology company providing therapeutics development solutions.
Cogent Biosciences
Cogent Biosciences is a biopharmaceutical company that develops therapies for solid cancer tumors.
Current Advisors List
Board_member
2015-05-01
Board_member
2018-12-01
Board_member
2015-01-01
Board_member
Board_member
Board_member
2015-10-01
Current Employees Featured
Garry Menzel President & Chief Executive Officer @ TCR2
President & Chief Executive Officer
2016-01-01
Robert Hofmeister Chief Scientific Officer @ TCR2
Chief Scientific Officer
2016-12-01
Patrick Baeuerle Founder @ TCR2
Founder
Greg Sieczkiewicz Chief IP Counsel @ TCR2
Chief IP Counsel
2015-01-01
Helen Ho Vice President, Head of Corporate Development @ TCR2
Vice President, Head of Corporate Development
2016-01-01
Rosemary Harrison Chief Business and Strategy Officer @ TCR2
Chief Business and Strategy Officer
2022-01-01
Founder
Stock Details
Investors List
Haitong International Securities Group
Haitong International Securities Group investment in Series B - TCR2
6 Dimensions Capital
6 Dimensions Capital investment in Series B - TCR2
Sirona Capital
Sirona Capital investment in Series B - TCR2
ArrowMark Partners
ArrowMark Partners investment in Series B - TCR2
Alexandria Venture Investments
Alexandria Venture Investments investment in Series B - TCR2
Syno Capital
Syno Capital investment in Series B - TCR2
curative ventures
curative ventures investment in Series B - TCR2
Hillhouse Capital Group
Hillhouse Capital Group investment in Series B - TCR2
Cathay Capital
Cathay Capital investment in Series B - TCR2
F2 Ventures
F2 Ventures investment in Series B - TCR2
Official Site Inspections
http://www.tcr2.com Semrush global rank: 4.37 M Semrush visits lastest month: 2.59 K
- Host name: aec037177372cc6cd.awsglobalaccelerator.com
- IP address: 3.33.251.168
- Location: Seattle United States
- Latitude: 47.6348
- Longitude: -122.3451
- Metro Code: 819
- Timezone: America/Los_Angeles
- Postal: 98109
